These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38905564)

  • 1. Canadian Thoracic Society Guidelines for Pharmacotherapy for Stable Chronic Obstructive Pulmonary Disease.
    Ebell MH
    Am Fam Physician; 2024 Jun; 109(6):581-582. PubMed ID: 38905564
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation 2003-Sixth World Congress. Focus on chronic obstructive pulmonary disease. 2-6 August 2003, Vancouver, Canada.
    Rossi AG
    IDrugs; 2003 Sep; 6(9):838-40. PubMed ID: 14565167
    [No Abstract]   [Full Text] [Related]  

  • 3. NICE guidelines for chronic obstructive pulmonary disease: implications for primary care.
    Gruffydd-Jones K; Jones MM
    Br J Gen Pract; 2011 Feb; 61(583):91-2. PubMed ID: 21276335
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.
    O'Donnell DE; Aaron S; Bourbeau J; Hernandez P; Marciniuk DD; Balter M; Ford G; Gervais A; Goldstein R; Hodder R; Kaplan A; Keenan S; Lacasse Y; Maltais F; Road J; Rocker G; Sin D; Sinuff T; Voduc N
    Can Respir J; 2007 Sep; 14 Suppl B(Suppl B):5B-32B. PubMed ID: 17885691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating guidelines into community practice: signs and symptoms are not enough.
    Yawn B
    Prim Care Respir J; 2011 Jun; 20(2):111-2. PubMed ID: 21597664
    [No Abstract]   [Full Text] [Related]  

  • 6. Update in Chronic Obstructive Pulmonary Disease 2020.
    Ritchie AI; Baker JR; Parekh TM; Allinson JP; Bhatt SP; Donnelly LE; Donaldson GC
    Am J Respir Crit Care Med; 2021 Jul; 204(1):14-22. PubMed ID: 33856972
    [No Abstract]   [Full Text] [Related]  

  • 7. The Rationale for GesEPOC in Our Environment.
    Arnedillo Muñoz A
    Arch Bronconeumol; 2017 Jun; 53(6):293-294. PubMed ID: 28495074
    [No Abstract]   [Full Text] [Related]  

  • 8. 2. Advances in pharmacotherapy for COPD.
    Ichinose M
    Intern Med; 2007; 46(2):81-4. PubMed ID: 17220603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.
    Salpeter SR
    Can Fam Physician; 2007 Aug; 53(8):1290-7. PubMed ID: 17872838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trends in pharmacotherapy of chronic obstructive pulmonary disease].
    Xie QM; Chen JQ; Bian LL
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 37(4):321-7. PubMed ID: 18705002
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?
    Calverley PM; Rennard SI
    Eur Respir J; 2004 Jun; 23(6):793-4. PubMed ID: 15218985
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some considerations in the revision of "the guideline for the diagnosis and treatment of chronic obstructive pulmonary disease"].
    Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):243-5. PubMed ID: 23945334
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of guidelines and the literature in the treatment of acute bronchospasm in chronic obstructive pulmonary disease.
    Pleasants RA
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):156S-63S. PubMed ID: 16945062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed?
    Luppi F; Beghé B; Richeldi L
    Am J Respir Crit Care Med; 2010 Jan; 181(2):102-3. PubMed ID: 20053967
    [No Abstract]   [Full Text] [Related]  

  • 15. [New bronchodilators and combinations in COPD treatment].
    Günay S; Sarıaydın M; Yılmaz Demirci N
    Tuberk Toraks; 2016 Sep; 64(3):240-245. PubMed ID: 28366158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bronchodilators in controlling COPD symptoms.
    Raisbeck E
    Community Nurse; 2000 Jun; 6(5):19-20. PubMed ID: 12778532
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease.
    Stoller JK
    N Engl J Med; 2002 Mar; 346(13):988-94. PubMed ID: 11919309
    [No Abstract]   [Full Text] [Related]  

  • 18. Does practice follow evidence-based guidelines? Adherence to GOLD guidelines in Portugal.
    Rodrigues C; Alfaro T; Fernandes L; Ferreira P; Silva S; Costa JC; Fernandes V; Seixas E; Viana R
    Pulmonology; 2019; 25(3):177-179. PubMed ID: 31000443
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bronchodilatators and exercise in COPD: effects, evaluation and strategy of use].
    Perez T
    Rev Pneumol Clin; 2002 Sep; 58(4 Pt 2):2S11-7. PubMed ID: 12458313
    [No Abstract]   [Full Text] [Related]  

  • 20. [COPD: regulations, guidelines, clinical pathways].
    de Lucas Ramos P; de Miguel Díez J; López Martín S; Rodríguez González-Moro JM
    Arch Bronconeumol; 2004 Mar; 40 Suppl 1():9-15. PubMed ID: 16137444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.